Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Grail survives adcomm vote as it awaits FDA decision
Grail has beaten the odds and seen a positive recommendation for its multi-cancer blood test Galleri from FDA advisors.
Ben Adams
Sep 24, 2026 9:10am
Siemens Healthineers, Novo team up on fatty liver testing
Sep 22, 2026 9:06am
FDA clears Aptitude’s Metrix molecular dx to test for COVID
Sep 18, 2026 8:55am
J&J to offload orthopedics unit in $20B deal to Apollo: report
Sep 14, 2026 8:40am
GE mulls $1B imaging chemicals maker deal: Financial Times
Sep 13, 2026 8:45am
Labcorp snaps up MLM Medical Labs to boost laboratory footprint
Sep 9, 2026 9:14am
